Differences in Treatment Approaches for Low-Risk and High-Risk MDS

Opinion
Video

Jamie L. Koprivnikar, MD, details how her treatment approaches differ for patients with low-risk versus high-risk myelodysplastic syndrome.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content